Drug Profile
Etonogestrel-releasing intrauterine system - Merck & Co.
Alternative Names: ENG-MIUS; MK-8342; ORG 299001; SCH 900342Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Hormonal contraceptives; Norpregnanes; Phenanthrenes; Progesterone congeners; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 11 Aug 2015 Discontinued - Phase-II for Pregnancy (Prevention) in Germany and the Netherlands (Intrauterine)
- 31 Oct 2014 Phase-II development is ongoing for Contraception/Pregnancy (Prevention)
- 27 Jul 2012 Phase-II development is ongoing for Contraception/Pregnancy (Prevention)